Anthony Vendetti
Stock Analyst at Maxim Group
(3.71)
# 815
Out of 4,735 analysts
71
Total ratings
25.81%
Success rate
17.33%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHST BioHarvest Sciences | Initiates: Buy | $12 | $5.80 | +106.81% | 1 | Dec 18, 2024 | |
| ACON Aclarion | Downgrades: Hold | n/a | $0.04 | - | 2 | Dec 13, 2024 | |
| NXL Nexalin Technology | Downgrades: Hold | n/a | $2.82 | - | 2 | Dec 5, 2024 | |
| TNON Tenon Medical | Maintains: Buy | $22 → $8 | $1.78 | +349.44% | 1 | Nov 15, 2024 | |
| SRTS Sensus Healthcare | Maintains: Buy | $12 → $14 | $6.84 | +104.68% | 5 | Nov 15, 2024 | |
| NUTX Nutex Health | Maintains: Buy | $45 → $50 | $38.50 | +29.87% | 2 | Nov 12, 2024 | |
| HSDT Helius Medical Technologies | Downgrades: Hold | n/a | $1.03 | - | 2 | Oct 16, 2024 | |
| CELH Celsius Holdings | Maintains: Buy | $65 → $50 | $26.81 | +86.50% | 7 | Sep 5, 2024 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $10 → $6 | $1.27 | +372.44% | 3 | Aug 21, 2024 | |
| BIAF bioAffinity Technologies | Initiates: Buy | $6 | $0.67 | +789.02% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.53 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $4.86 | +208.64% | 6 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.78 | +671.70% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.11 | +23.30% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.19 | +128.31% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.52 | +481.40% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.40 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $5.99 | -66.61% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $1.75 | +7,042.86% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.99 | +607.07% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.49 | - | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $32.87 | -23.94% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.34 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $140 | $0.26 | +53,663.44% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $2.91 | +71.82% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.65 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.23 | +143.90% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $19.58 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $160 | $0.18 | +88,788.89% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $42.89 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $1.81 | +39,679.01% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.07 | -50.35% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.70 | - | 1 | May 31, 2016 |
BioHarvest Sciences
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $5.80
Upside: +106.81%
Aclarion
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.04
Upside: -
Nexalin Technology
Dec 5, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.82
Upside: -
Tenon Medical
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $1.78
Upside: +349.44%
Sensus Healthcare
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $6.84
Upside: +104.68%
Nutex Health
Nov 12, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $38.50
Upside: +29.87%
Helius Medical Technologies
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.03
Upside: -
Celsius Holdings
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $26.81
Upside: +86.50%
Dermata Therapeutics
Aug 21, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $1.27
Upside: +372.44%
bioAffinity Technologies
Jul 23, 2024
Initiates: Buy
Price Target: $6
Current: $0.67
Upside: +789.02%
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $4.53
Upside: -
May 9, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $4.86
Upside: +208.64%
Jan 30, 2024
Initiates: Buy
Price Target: $6
Current: $0.78
Upside: +671.70%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $8.11
Upside: +23.30%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $2.19
Upside: +128.31%
Oct 5, 2023
Initiates: Buy
Price Target: $3
Current: $0.52
Upside: +481.40%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.40
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $5.99
Upside: -66.61%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $1.75
Upside: +7,042.86%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.99
Upside: +607.07%
Mar 30, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.49
Upside: -
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $32.87
Upside: -23.94%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.34
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $240 → $140
Current: $0.26
Upside: +53,663.44%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $2.91
Upside: +71.82%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.65
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $1.23
Upside: +143.90%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $19.58
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $160
Current: $0.18
Upside: +88,788.89%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $42.89
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $1.81
Upside: +39,679.01%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.07
Upside: -50.35%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $0.70
Upside: -